Regulators have few ways to prevent fake medicines from reaching patients.
Reuters (3/12, Berkrot) Lack of regulations make it hard to stop fake medications from getting to patients, and laws seeking to help may be years from enacted. Criminal and terrorist organizations are lured to counterfeit drug trade due to smaller penalties than illegal drug running. Deputy director of the FDA’s Office of New Drugs, Sandra Kweder, said, “The business about counterfeit Avastin [bevacizumab] really demonstrates how easy it is to be fooled.” Kweder added, “Often these outfits, they’re in business one day and out the next.”
